UPDATE 1-Raptor plans to advance development of brain disorder drug

December 10, 2015 12:06 PM

16 0

Dec 10 Raptor Pharmaceutical Corp said it plans to advance development of its brain disorder drug to a registration study, despite it failing to show statistical significance in a trial.

The drug, RP103, is being evaluated in patients with Huntington's Disease, a type of neurodegenerative genetic disorder that affects muscle coordination and leads to mental decline and behavioral symptoms.

Also read: Synergy Pharma's irritable bowel drug succeeds in key study

Read more

To category page

Loading...